Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
1.15B | 895.40M | 642.42M | 535.82M | 447.89M | Gross Profit |
1.15B | 895.40M | 642.42M | 535.82M | 447.89M | EBIT |
0.00 | 0.00 | 56.19M | 48.75M | -94.66M | EBITDA |
165.59M | 0.00 | 61.32M | 58.05M | -84.01M | Net Income Common Stockholders |
118.83M | 85.98M | 39.40M | 38.32M | -74.64M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.18B | 863.92M | 774.17M | 206.38M | 299.41M | Total Assets |
3.73B | 2.95B | 2.37B | 2.12B | 1.95B | Total Debt |
119.54M | 128.69M | 128.61M | 128.53M | 128.45M | Net Debt |
-2.07M | 62.80M | 83.17M | 86.42M | 64.99M | Total Liabilities |
2.94B | 1.51B | 1.95B | 1.69B | 1.65B | Stockholders Equity |
794.00M | 661.03M | 421.66M | 426.08M | 303.22M |
Cash Flow | Free Cash Flow | |||
300.89M | 335.03M | 206.61M | 173.13M | 42.64M | Operating Cash Flow |
305.12M | 338.19M | 208.94M | 175.28M | 44.71M | Investing Cash Flow |
-243.69M | -493.81M | -193.38M | -183.01M | -74.93M | Financing Cash Flow |
-4.23M | 130.95M | 2.18M | 1.38M | 56.30M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $2.10B | 18.25 | 16.27% | ― | 28.17% | 28.63% | |
74 Outperform | $1.13B | 15.88 | 8.66% | 4.74% | 21.61% | 273.90% | |
72 Outperform | $1.56B | 16.31 | 28.26% | 1.10% | 36.21% | 18.17% | |
70 Outperform | $1.80B | 76.66 | 10.41% | ― | 158.57% | ― | |
70 Outperform | $1.24B | 31.92 | 13.60% | ― | 50.21% | 37.28% | |
64 Neutral | $13.21B | 9.26 | 9.39% | 4.87% | 16.14% | -8.87% | |
54 Neutral | $1.90B | ― | -31.05% | ― | 20.94% | 16.23% |
On January 31, 2025, Skyward Re, a subsidiary of Skyward Specialty Insurance Group, commuted its Loss Portfolio Transfer and Adverse Development and Retrocession Agreement with R&Q Re, receiving $11.7 million in cash and strengthening loss reserves by $25.3 million. The company reported strong preliminary fourth quarter 2024 results with a 20.8% increase in gross written premiums to $388.4 million and net income of $14.4 million. Looking ahead to 2025, Skyward Specialty anticipates net income between $138.0 million and $150.0 million and a combined ratio between 91.0% and 92.0%, reflecting a positive outlook for continued growth and strategic investments in its business divisions.